In a recent meta-analysis study, CCL2 was identified as an important marker for the progression of osteoarthritis (OA) with the authors concluding that it may serve as a potential biomarker for the diagnosis of OA [35]. This evidence concerns the gene CCL2 and osteoarthritis.